Global X Management Company’s Medifast MED Stock Holding History

Global X Management Company’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$30K	Buy	190 +28	+17%	+$3.58K	﹤0.01%	1162
2018 Q1	$15K	Hold	162	–	–	﹤0.01%	1126
2017 Q4	$11K	Hold	162	–	–	﹤0.01%	1041
2017 Q3	$10K	Buy	162 +7	+5%	+$348	﹤0.01%	1101
2017 Q2	$6K	Buy	+155	New	+$6.74K	﹤0.01%	1206

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Global X Management Company's MED Position: Q2 2018 in Review

Global X Management Company increased its Medifast (MED) stake by 17% in Q2 2018, buying an estimated $3.58K and bringing the position to 190 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #1162.

Global X Management Company first reported a position in MED in Q2 2017 and has held it in 5 quarters since. 258 funds tracked by Wall St. Rank hold MED as of Q2 2018.

Global X Management Company held 190 shares of Medifast worth $30K as of Q2 2018.
Global X Management Company bought 28 Medifast shares in Q2 2018, an estimated $3.58K.
Medifast made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1162 holding.
Global X Management Company first reported a position in Medifast in Q2 2017 and has held it in 5 quarters since.
258 funds tracked by Wall St. Rank held Medifast as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.